Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Catalent Inc (NY: CTLT )

115.15 USD +2.35 (+2.08%)
Official Closing Price Updated: 5:25 PM EST, Feb 24, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 946,188
Open 112.61
Bid (Size) 112.80 (1)
Ask (Size) 114.98 (22)
Prev. Close 112.80
Today's Range 112.26 - 115.54
52wk Range 31.04 - 127.68
Shares Outstanding 133,369,281
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Catalent, Inc. to Present at the SVB Leerink 10th Annual Global Healthcare Conference
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health... 
From Business Wire News Releases
Catalent Announces Upsizing and Pricing of Private Offering of Senior Unsecured Notes Due 2029
Catalent, Inc. (“Catalent”) (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and... 
From Business Wire News Releases

Performance

YTD
+11.01%
+11.01%
1 Month
-0.50%
-0.50%
3 Month
+21.65%
+21.65%
6 Month
+30.33%
+30.33%
1 Year
+105.92%
+105.92%

More News

Read More
Catalent Announces Launch of Private Offering of $475 Million of Senior Unsecured Notes Due 2029
From Business Wire News Releases
Intra-Cellular Therapies Discloses New Drug Candidate For Dementia Related Episodes
Tags Benzinga ITCI Market News
From Benzinga
VB, ENPH, MDB, CTLT: Large Inflows Detected at ETF
Tags ETFs
From ETF Channel
Catalent, Inc. Reports Second Quarter Fiscal 2021 Results
From Business Wire News Releases
Should Investors Worry About Moderna's Vaccine Delays?
Tags MRNA REGN CTLT
From Motley Fool
IBD Screen Of The Day: Catalent, HubSpot Offer Two Tales Of Relative Strength
From Investor's Business Daily
Moderna Hits a Short-Term Vaccine Manufacturing Delay, Still on Track for First 100 Million Doses by End of March
Tags Market News MRNA CTLT
From Motley Fool
Let’s stick to facts about COVID-19 vaccines: There aren’t ‘dozens’ of drug companies who can step in to produce more
Tags CH:LONN ALNY NVS
From MarketWatch
Catalent: Q2 Earnings Insights
Tags Earnings BZI/Recaps Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.